½üÈÕ£¬Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº£¨¹ãÖݽ¡¿µÔº£©ÀîÆ½³¬¸±Ñо¿Ô±£¨µÚ12Åú»áÔ±£©ÓëºôÎü¼²²¡È«¹úÖØµãʵÑéÊÒ³ÂÁè½ÌÊÚ¡¢³ÂÐÂÎÄÑо¿Ô±ºÏ×÷ÔÚ±ÇÅçÒßÃçµÄ×÷ÓûúÖÆÓÈÆäÊÇð¤Ä¤sIgA£¨·ÖÃÚÐÍÃâÒßÇòµ°°×A£©¿¹ÌåÑо¿È¡µÃ½øÕ¹¡£ йڲ¡¶¾³ÖÐøÍ»±ä²¢ÔöÇ¿Á˶ÔÉϺôÎüµÀµÄ¸ÐȾÄÜÁ¦£¬ËäÈ»¼¡Èâ×¢ÉäµÄÒßÃç¿ÉÒÔ¼õÉÙÖØÖ¢¼²²¡£¬È´²»ÄÜÓÐЧԤ·À°ÂÃÜ¿ËÈÖ±äÒìÖêµÄ¸ÐȾºÍ´«²¥¡£¶àÏî¹ú¼ÊÑо¿·¢ÏÖ£¬¸ÐȾйڲ¡¶¾ºó²úÉúµÄ±Çð¤Ä¤Sµ°°×ÌØÒìÐÔsIgA¿¹ÌåˮƽԽ¸ß£¬ÔٴθÐȾµÄ·çÏÕÔ½µÍ¡£È»¶ø£¬ÉϺôÎüµÀÓÈÆäÊDZÇð¤Ä¤ sIgA ¿¹ÌåÔÚÔ¤·À¸ÐȾµÄ×÷ÓúͻúÖÆØ½ÐèÑо¿¡£ Ñо¿ÍŶÓǰÆÚÑÐÖÆÁË»ùÓÚ°ÂÃÜ¿ËÈÖBA.1±äÒìÖêµÄ±ÇÅçÐÍÖØ×éÈË5ÐÍÏÙ²¡¶¾ÔØÌå°ÂÃÜ¿ËÈÖÒßÃçAd5-S-Omicron£¨NB2155£©£¬ÔÚСÊóÄ£ÐÍÖÐ֤ʵ£¬¾±ÇÃâÒß¿ÉÒÔÔÚºôÎüµÀð¤Ä¤ºÍÈ«Éí£¨ÏµÍ³£©ÓÕµ¼²úÉú¹ãÆ×µÄºôÎüµÀð¤Ä¤sIgA¿¹ÌåºÍTϸ°û·´Ó¦¡£µ±°Ñ±ÇÅçÒßÃçÖ¾Ô¸ÕßµÄÏ´±ÇÒº£¨NLF£©µÎ±Ç¹ý¼Ì¸øÐ¡Ê󣬿ÉʹСÊóµÖÓù°ÂÃÜ¿ËÈֵĹ¥¶¾¸ÐȾ£¨Signal Transduct Target Ther. 2023 Apr 17;8(1):167£¬ÀîÆ½³¬¸±Ñо¿Ô±Îª¹²Í¬Í¨Ñ¶×÷Õߣ©¡£ Ϊ½øÒ»²½·ÖÎö±ÇÇ»ð¤Ä¤¿¹Ì壬Ñо¿ÈËԱͬʱ²É¼¯Ö¾Ô¸Õß±ÇÅçÒßÃçºóµÄÏ´±ÇÒº¼°ÑªÑù£¬²¢Ìá´¿±ÇÇ»sIgA¡¢ÑªÇåIgG¡¢ÑªÇåIgA½øÐбȽϡ£·¢ÏÖ±ÇÇ»sIgAÖкͰÂÃÜ¿ËÈÖBA.5±äÒìÖêµÄÄÜÁ¦±ÈѪÇåIgG¼°IgAǿԼ100±¶¡£ÖµµÃ×¢ÒâµÄÊÇ£¬µ±ÑªÇåIgGºÍIgAʧȥ¶Ô±äÒìÖêBQ.1.1¡¢EG.5¡¢XBB¡¢BA.2.86¡¢JN.1µÄÖкÍÄÜÁ¦Ê±£¬±ÇÇ»sIgAÈÔÄÜǿЧÖкÍÕâЩ±äÒìÖ꣨°ëÒÖ֯ō¶ÈIC50 = 23-48ÄÉĦ¶û£©£¬±íÃ÷±ÇÅçÒßÃçÓÕµ¼µÄ±ÇÇ»sIgA±ÈѪÇ忹Ìå¾ßÓиüÇ¿µÄµÖÓù±äÒìÖêÌÓÒݵÄÄÜÁ¦¡£Í¬Ê±£¬Ñо¿·¢ÏÖ±ÇÇ»sIgA¶Ô°ÂÃÜ¿ËÈÖ±äÒìÖêµÄ½áºÏ»îÐÔÏÔÖøÇ¿ÓÚѪÇåIgGºÍIgA¡£Îª±È½ÏÌá´¿µÄÈ˱ÇÇ»sIgA¡¢ÑªÇåIgG¡¢ÑªÇåIgAµÖÓù°ÂÃÜ¿ËÈÖXBB.1.1¸ÐȾµÄЧ¹û£¬ÀûÓÃСÊó¹¥¶¾Ä£ÐÍ֤ʵ£¬½ÓÊܱÇÅçйÚÒßÃçÕßµÄsIgAµÎ±ÇµÄСÊó×îÄÜÓÐЧµÖÓù¸ÐȾ¡£´ËÍ⣬Ҳ·¢ÏÖ±ÇÇ»sIgA±ÈѪÇåIgGºÍIgA¸üÄÜÓÐЧ×è¶Ïйڲ¡¶¾Spike½éµ¼µÄϸ°û¼äÈںϣ¬Ìáʾ¶Ô·Àֹйڲ¡¶¾ÔÚ±ÇÇ»ÉÏÆ¤Ï¸°û¼äÀ©É¢¾ßÓÐÖØÒªÒâÒå¡£ ͨ¹ýÓÃ1ÉýÉúÀíÑÎË®¶ÔÖ¾Ô¸Õß³¹µ×Ï´±Ç²¢¼ì²âÏ´±ÇÒºÖеĿ¹Ì庬Á¿£¬·¢ÏÖ±ÇÇ»ÄÚº¬ÓдóÁ¿µÄsIgA¿¹Ì壨8.2ºÁ¿Ë£©¶ø½öÓÐÉÙÁ¿IgG£¨1.3ºÁ¿Ë£©¡£Óëµ¥ÌåµÄѪÇåIgA²»Í¬£¬±ÇÇ»sIgA Ö÷ÒªÒÔ¶þ¾ÛÌåºÍ¶à¾ÛÌåÐÎʽ´æÔÚ£¬Ô¼Õ¼±Çð¤Ä¤×ܵ°°×µÄ40%¡£ÀûÓÃÒ»ÖêsIgAµ¥¿Ë¡¿¹Ìå×÷Ϊ±ê׼Ʒ£¬Ñо¿ÈËÔ±»¹²âËã³ö±ÇÅçºó¿¹ÔÌØÒìÐÔIgA¿¹ÌåԼΪ±ÇÇ»×ÜIgAµÄ2.6-3.9%¡£ÓÐȤµÄÊÇ£¬ÔÚ³¹µ×ÇåÏ´±ÇÇ»ºó£¬±ÇÇ»ÖеÄsIgAº¬Á¿¿ÉÔÚ¼¸Ð¡Ê±ÄÚѸËÙ»Ö¸´£¬ÌáʾÎðÐèµ£ÓDzμÓÓÎÓ¾µÈË®ÉÏÔ˶¯¶øÓ°Ïì±ÇÇ»ð¤Ä¤ÃâÒß¡£±¾Ñо¿ÓÐÖúÓÚ²ûÃ÷ÉϺôÎüµÀð¤Ä¤sIgA µÄ¹¦ÄܺÍÌØÕ÷£¬Ö¤ÊµÁË¿ª·¢ÄÜÓÕµ¼±ÇÇ»ð¤Ä¤sIgAµÄйÚÒßÃçµÄ±ØÒªÐÔ£¬Ò²¶Ô¿ª·¢Õë¶ÔÆäËûºôÎüµÀ²¡ÔÌåµÄ±ÇÅçÒßÃç¾ßÓÐÖ¸µ¼ÒâÒå¡£ ÉÏÊöÑо¿³É¹ûÒÔ¡°Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies¡± ΪÌâ·¢±íÔÚSignal Transduction and Targeted TherapyÆÚ¿¯ÉÏ£¨https://www.nature.com/articles/s41392-024-01906-0£©¡£ºôÎü¼²²¡È«¹úÖØµãʵÑéÊÒ³ÂÁè½ÌÊÚΪ±¾ÂÛÎĵÄ×îºóͨѶ×÷Õß¡¢³ÂÐÂÎÄÑо¿Ô±ºÍ¹ãÖݽ¡¿µÔºÀîÆ½³¬¸±Ñо¿Ô±£¨µÚ12Åú»áÔ±£©Îª¹²Í¬Í¨Ñ¶×÷Õß¡£ºôÎü¼²²¡È«¹úÖØµãʵÑéÊÒ³Â˼²©Ê¿¡¢¹ãÖݽ¡¿µÔº²©Ê¿Ñо¿ÉúÕÅÕýÔ¶¡¢ºôÎü¼²²¡È«¹úÖØµãʵÑéÊÒÍôǬ¸±Ñо¿Ô±ºÍÑîç÷¸±Ñо¿Ô±Îª¹²Í¬µÚÒ»×÷Õß¡£·ëÁ¢Ç¿Ñо¿Ô±£¨µÚ4Åú»áÔ±£©ÔÚÑо¿ÆÚ¼ä¸øÓèÁË´óÁ¦Ö§³Ö¡£¸ÃÑо¿µÃµ½¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢Öйú¿ÆÑ§ÔºÇàÄ괴дٽø»á£¨2022361£©¡¢¹ãÖÝʵÑéÊÒ¡¢ºôÎü¼²²¡È«¹úÖØµãʵÑéÊҵȵÄ×ÊÖú¡£

ͼ1. ±ÇÇ»sIgA±ÈѪÇ忹Ìå¾ßÓиüǿЧÇÒ¸ü¹ãÆ×µÄÖкͲ¡¶¾»îÐÔ ÎÄÕÂÁ´½Ó£º 1.Chen S, et al. Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies. Signal Transduct Target Ther. 2024 Jul 22;9:190 (https://doi.org/10.1038/s41392-024-01906-0) |